232 related articles for article (PubMed ID: 25916208)
1. Orthotopic inflammation-related pancreatic carcinogenesis in a wild-type mouse induced by combined application of caerulein and dimethylbenzanthracene.
Liang C; Wang Z; Wu L; Wang C; Yu BH; Yao XZ; Wang XL; Li YY
Tumour Biol; 2015 Sep; 36(10):7557-68. PubMed ID: 25916208
[TBL] [Abstract][Full Text] [Related]
2. Pancreatic intraepithelial neoplasia and ductal adenocarcinoma induced by DMBA in mice.
Osvaldt AB; Wendt LR; Bersch VP; Backes AN; de Cássia A Schumacher R; Edelweiss MI; Rohde L
Surgery; 2006 Nov; 140(5):803-9. PubMed ID: 17084724
[TBL] [Abstract][Full Text] [Related]
3. Early requirement of Rac1 in a mouse model of pancreatic cancer.
Heid I; Lubeseder-Martellato C; Sipos B; Mazur PK; Lesina M; Schmid RM; Siveke JT
Gastroenterology; 2011 Aug; 141(2):719-30, 730.e1-7. PubMed ID: 21684285
[TBL] [Abstract][Full Text] [Related]
4. Effect of cholecystokinin analogue caerulein and cholecystokinin antagonist lorglumide on pancreatic carcinogenesis in the rat.
Sperti C; Militello C; Rovati L; Behboo R; Khajeturian E; Perasole A; Alaggio R; Pedrazzoli S
J Surg Oncol; 1994 Sep; 57(1):11-6. PubMed ID: 8065144
[TBL] [Abstract][Full Text] [Related]
5. Pancreatic intraepithelial neoplasia and ductal adenocarcinoma induced by DMBA in mice: effects of alcohol and caffeine.
Wendt LR; Osvaldt AB; Bersch VP; Schumacher Rde C; Edelweiss MI; Rohde L
Acta Cir Bras; 2007; 22(3):202-9. PubMed ID: 17546293
[TBL] [Abstract][Full Text] [Related]
6. Lipocalin-2 Promotes Pancreatic Ductal Adenocarcinoma by Regulating Inflammation in the Tumor Microenvironment.
Gomez-Chou SB; Swidnicka-Siergiejko AK; Badi N; Chavez-Tomar M; Lesinski GB; Bekaii-Saab T; Farren MR; Mace TA; Schmidt C; Liu Y; Deng D; Hwang RF; Zhou L; Moore T; Chatterjee D; Wang H; Leng X; Arlinghaus RB; Logsdon CD; Cruz-Monserrate Z
Cancer Res; 2017 May; 77(10):2647-2660. PubMed ID: 28249896
[TBL] [Abstract][Full Text] [Related]
7. Ablation of sensory neurons in a genetic model of pancreatic ductal adenocarcinoma slows initiation and progression of cancer.
Saloman JL; Albers KM; Li D; Hartman DJ; Crawford HC; Muha EA; Rhim AD; Davis BM
Proc Natl Acad Sci U S A; 2016 Mar; 113(11):3078-83. PubMed ID: 26929329
[TBL] [Abstract][Full Text] [Related]
8. Hes1 Controls Exocrine Cell Plasticity and Restricts Development of Pancreatic Ductal Adenocarcinoma in a Mouse Model.
Hidalgo-Sastre A; Brodylo RL; Lubeseder-Martellato C; Sipos B; Steiger K; Lee M; von Figura G; Grünwald B; Zhong S; Trajkovic-Arsic M; Neff F; Schmid RM; Siveke JT
Am J Pathol; 2016 Nov; 186(11):2934-2944. PubMed ID: 27639167
[TBL] [Abstract][Full Text] [Related]
9. The epigenetic regulators Bmi1 and Ring1B are differentially regulated in pancreatitis and pancreatic ductal adenocarcinoma.
Martínez-Romero C; Rooman I; Skoudy A; Guerra C; Molero X; González A; Iglesias M; Lobato T; Bosch A; Barbacid M; Real FX; Hernández-Muñoz I
J Pathol; 2009 Oct; 219(2):205-13. PubMed ID: 19585519
[TBL] [Abstract][Full Text] [Related]
10. Inflammatory cytokines regulate the expression of glycosyltransferases involved in the biosynthesis of tumor-associated sialylated glycans in pancreatic cancer cell lines.
Bassagañas S; Allende H; Cobler L; Ortiz MR; Llop E; de Bolós C; Peracaula R
Cytokine; 2015 Sep; 75(1):197-206. PubMed ID: 25934648
[TBL] [Abstract][Full Text] [Related]
11. Activation of Notch signaling in tumorigenesis of experimental pancreatic cancer induced by dimethylbenzanthracene in mice.
Kimura K; Satoh K; Kanno A; Hamada S; Hirota M; Endoh M; Masamune A; Shimosegawa T
Cancer Sci; 2007 Feb; 98(2):155-62. PubMed ID: 17297654
[TBL] [Abstract][Full Text] [Related]
12. Overexpression of fibroblast growth factor receptor 4 in high-grade pancreatic intraepithelial neoplasia and pancreatic ductal adenocarcinoma.
Motoda N; Matsuda Y; Onda M; Ishiwata T; Uchida E; Naito Z
Int J Oncol; 2011 Jan; 38(1):133-43. PubMed ID: 21109934
[TBL] [Abstract][Full Text] [Related]
13. Tumor-associated macrophages exhibit pro- and anti-inflammatory properties by which they impact on pancreatic tumorigenesis.
Helm O; Held-Feindt J; Grage-Griebenow E; Reiling N; Ungefroren H; Vogel I; Krüger U; Becker T; Ebsen M; Röcken C; Kabelitz D; Schäfer H; Sebens S
Int J Cancer; 2014 Aug; 135(4):843-61. PubMed ID: 24458546
[TBL] [Abstract][Full Text] [Related]
14. Nr5a2 heterozygosity sensitises to, and cooperates with, inflammation in KRas(G12V)-driven pancreatic tumourigenesis.
Flandez M; Cendrowski J; Cañamero M; Salas A; del Pozo N; Schoonjans K; Real FX
Gut; 2014 Apr; 63(4):647-55. PubMed ID: 23598351
[TBL] [Abstract][Full Text] [Related]
15. Nicotine promotes initiation and progression of KRAS-induced pancreatic cancer via Gata6-dependent dedifferentiation of acinar cells in mice.
Hermann PC; Sancho P; Cañamero M; Martinelli P; Madriles F; Michl P; Gress T; de Pascual R; Gandia L; Guerra C; Barbacid M; Wagner M; Vieira CR; Aicher A; Real FX; Sainz B; Heeschen C
Gastroenterology; 2014 Nov; 147(5):1119-33.e4. PubMed ID: 25127677
[TBL] [Abstract][Full Text] [Related]
16. Early expression of the fractalkine receptor CX3CR1 in pancreatic carcinogenesis.
Celesti G; Di Caro G; Bianchi P; Grizzi F; Marchesi F; Basso G; Rahal D; Delconte G; Catalano M; Cappello P; Roncalli M; Zerbi A; Montorsi M; Novelli F; Mantovani A; Allavena P; Malesci A; Laghi L
Br J Cancer; 2013 Oct; 109(9):2424-33. PubMed ID: 24084767
[TBL] [Abstract][Full Text] [Related]
17. Origin of pancreatic ductal adenocarcinoma from atypical flat lesions: a comparative study in transgenic mice and human tissues.
Aichler M; Seiler C; Tost M; Siveke J; Mazur PK; Da Silva-Buttkus P; Bartsch DK; Langer P; Chiblak S; Dürr A; Höfler H; Klöppel G; Müller-Decker K; Brielmeier M; Esposito I
J Pathol; 2012 Apr; 226(5):723-34. PubMed ID: 21984419
[TBL] [Abstract][Full Text] [Related]
18. Metformin suppresses cancer initiation and progression in genetic mouse models of pancreatic cancer.
Chen K; Qian W; Jiang Z; Cheng L; Li J; Sun L; Zhou C; Gao L; Lei M; Yan B; Cao J; Duan W; Ma Q
Mol Cancer; 2017 Jul; 16(1):131. PubMed ID: 28738823
[TBL] [Abstract][Full Text] [Related]
19. Stem cell marker nestin is critical for TGF-β1-mediated tumor progression in pancreatic cancer.
Su HT; Weng CC; Hsiao PJ; Chen LH; Kuo TL; Chen YW; Kuo KK; Cheng KH
Mol Cancer Res; 2013 Jul; 11(7):768-79. PubMed ID: 23552743
[TBL] [Abstract][Full Text] [Related]
20. Intracellular HMGB1 as a novel tumor suppressor of pancreatic cancer.
Kang R; Xie Y; Zhang Q; Hou W; Jiang Q; Zhu S; Liu J; Zeng D; Wang H; Bartlett DL; Billiar TR; Zeh HJ; Lotze MT; Tang D
Cell Res; 2017 Jul; 27(7):916-932. PubMed ID: 28374746
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
